Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Global Net Lease Announces Release Date for Fourth Quarter and Full Year 2023 Results
-
Axalta Releases Fourth Quarter and Full Year 2023 Results
-
Agora, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 26, 2024
-
Global Net Lease Announces Release Date for Fourth Quarter and Full Year 2023 Results
-
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
-
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
-
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
-
Net Asset Value(s)
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Wincanton Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SMART METERING SYSTEMS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LXI REIT PLC
-
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
-
Mandatory Notification of Trade
-
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Custodian Property Income Reit
-
Cloudbeds reveals highest revenue-generating OTAs for independent properties
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Abrdn Property Income Trust
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Residential Properties REIT PLC
-
Golden Triangle Ventures Activates Phase One of Destino Ranch Development, an Immersive Entertainment Venue, Through Its Entertainment Division
-
Gaming Intelligence Names Optimove’s Motti Colman to its 2024 Hot 50 List
-
European Energy A/S: Financial Calendar 2024
-
DSV, 1090 - Notice of Annual General Meeting
-
Fraser Institute News Release: Federal day-care program has resulted in little-to-no change for industry employment nor the female labour force participation rate
-
Fortuna Announces GHG Emissions Reduction Target for 2030 and Long-Term Objectives to 2050
-
KONA I to introduce biometric smart cards with IDEX Biometrics in Japan
-
Notice of the Annual General Meeting of Nokia Corporation
-
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
-
KONA I to introduce biometric smart cards with IDEX Biometrics in Japan
-
Assosia and Simpson Associates Team Up to Unlock Product Matching Potential with Machine Learning
-
Wiztrust Protect secures a market capitalization of over €1,000 billion, doubling its scope since 2021
-
Eika Boligkreditt AS: Report for the fourth quarter 2023
-
Net Asset Value(s) - Correction
-
Initiation of share repurchase programme
-
Talk Is Cheap, Action's Now: United Renewables Pushes Business Change
-
Talk Is Cheap, Action's Now: United Renewables Pushes Business Change
-
Heineken® Says “Cheers To The Real Hardcore Fans,” – But They Aren’t Who You Think
-
Release of Marimekko's Financial Statements Bulletin for the year 2023
-
Share Buyback Transaction Details February 1 – 7, 2024
-
Proposals of Sampo plc's Board of Directors and its Audit Committee to the Annual General Meeting and Remuneration Policy for Governing Bodies have been published
-
Li Auto Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
-
Festi hf.: Presentation of Q4 and 12M 2023 results
-
Temenos achieves market-leading Net Promoter Score highlighting trusted status and customer success
-
Vow ASA: Vow secures EUR 19.3 million cruise order and option
-
CallTower Secures Coveted Five9 2023 Global Partner Award
-
Nilörn has today signed a partnership agreement with Worldfavor
-
VEON’s Kyivstar Nominated for the GLOMO in “Best Mobile Innovation” for Emergency and Humanitarian Connectivity
-
Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle
